Light Mode
$12.80 ↑ +0.00 (+0.00%) Trading Up from the previous close of $12.80, $1.20 below the day’s high of $14.00
+13.00 (+10833.33%) / 6M
Momentum, market sentiment, and recent alerts
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.